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The renin-angiotensin system (RAS) is 
one of the most important systems for 
blood pressure regulation and sodium 
homeostasis in patients with chronic 
kidney disease (CKD). As well as sys-
temic RAS activity, the role of the local 
RAS in specific tissues and organs, in-
cluding the kidneys, has been the focus 
of many studies. All three components 
of the RAS co-exist in the kidneys. 
These components are locally activated 
and play a role in the development and 
progression of various kidney diseases 
[1]. The RAS is the target of many anti-
hypertensive drugs due to its import-
ant role in blood pressure regulation. 
However, inappropriate activation of 
the intrarenal RAS due to arterioscle-
rotic narrowing of the renal arterioles 
is a major contributor to excess sodi-
um retention, and an important mech-
anism underlying elevated blood pres-
sure and progression of CKD [2]. 
Angiotensinogen (AGT) is the only 
known substrate for renin, which is 
the rate-determining enzyme of the 
RAS. Therefore, changes in AGT or 
renin levels affect RAS activity, as evi-
denced by an in vitro study [3]. Kobori 
et al. [4] revealed that urinary angioten-
sinogen (UAGT) levels are correlated 
with intrarenal AGT and angiotensin 
II levels in angiotensin II-induced 
and spontaneously hypertensive rats. 
It is unknown whether UAGT, which 
is largely synthesized in the proximal 
kidney tubules, can be used as a mark-
er of intrarenal RAS activity in patients 
with CKD. However, Yamamoto et al. 
[5] demonstrated that high UAGT levels 
are present in patients with a low es-
timated glomerular filtration rate and 
high urinary protein excretion rate, 
and that treatment with the angioten-
sin receptor blocker losartan reduces 
UAGT levels. 
As previously mentioned, the RAS 
also plays an important role in sodium 
homeostasis. Several epidemiological 
studies have reported that the preva-
lence of elevated blood pressure is di-
rectly related to dietary salt intake in 
all populations with a sodium intake of 
50 to 100 mmol/day [6,7], whereas the 
prevalence of hypertension is rare in 
populations with low salt intake. 
Salt loading usually induces urinary 
salt excretion, called pressure natriure-
sis; however, some individuals have a 
blunted response to high salt intake. 
Salt sensitivity describes individuals 
whose blood pressure decreases and 
increases during periods of salt restric-
tion and loading, respectively. Risk fac-
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tors for salt sensitivity include old age, obesity, diabetes, 
and CKD. Although the association between salt sen-
sitivity and an increased risk of hypertension and car-
diovascular diseases is clear, the underlying pathogenic 
mechanism is not fully understood. 
Considering that both activation of the intrarenal RAS 
and salt sensitivity contribute to elevated blood pres-
sure, we postulate that there is a relationship between 
intrarenal RAS activity and salt sensitivity. However, ev-
idence supporting this association has been conflicting. 
In a population-based dietary feeding study of 100 ran-
domly selected participants, Rebholz et al. [8] demon-
strated the relationship between salt sensitivity and in-
trarenal RAS activity, indexed by UAGT. However, the 
study was conducted on individuals without kidney dis-
ease. Kim et al. [9] investigated this association in a study 
of 1,955 patients with CKD. The association between 
UAGT excretion and elevated blood pressure, as well as 
its relationship with intra-renal RAS activity and dietary 
sodium, was determined. The study subjects were from 
the Korean Cohort Study for Outcome in Patients with 
Chronic Kidney Disease (KNOW-CKD) study, which is a 
patient-based multicenter cohort study involving nine 
tertiary care hospitals in South Korea. The authors re-
ported that enhanced intrarenal RAS activity, as indi-
cated by a high urinary angiotensinogen-to-creatinine 
ratio (UAGT/Cr), and high urinary sodium (UNa) ex-
cretion, as indicated by a high 24-hour UNa, were both 
associated with high systolic blood pressure in patients 
with CKD. The group in the highest UAGT/Cr and 24-
hour UNa tertile were also in the highest systolic blood 
pressure tertile, with an odds ratio of 2.4 compared to 
the rest of the group. Systolic blood pressure increased 
by 2.0 mmHg for every 100 mEq/day increase in 24-hour 
UNa (p = 0.027), which is a smaller change than reported 
in a study based on the Korean National Health and Nu-
tritional Examination Survey, where a 100 mEq/day in-
crease in 24-hour UNa was associated with a 6.1 mmHg 
increase in systolic blood pressure. This further sup-
ports the concept of salt sensitivity, which could differ 
between individuals with and without CKD. An interest-
ing finding from the study was that there was no correla-
tion between UAGT excretion and UNa excretion, which 
contrasts with previous studies indicating that high salt 
intake leads to an increase in intrarenal RAS activity in 
salt-sensitive patients [10]. The study by Kim et al. [9] 
had several limitations. First, due to its cross-section-
al nature, causal relationships between blood pressure, 
24-hour UNa, and UAGT/Cr were difficult to determine. 
Second, a subgroup analysis of salt-sensitive and salt-re-
sistant groups would have provided further insight into 
how UAGT, UNa excretion, and salt sensitivity interact 
in patients with CKD. Finally, it would have been in-
teresting to see how enhanced intrarenal RAS activity 
affected long-term clinical outcomes, such as cardio-
vascular and kidney outcomes, in patients with CKD. 
Nonetheless, the study represents a leap forward in our 
understanding of a relatively novel biomarker and holds 
considerable promise to improve the quality of care for 
patients with CKD.
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